6
views
0
recommends
+1 Recommend
1 collections
    0
    shares

      Call for Papers: Sex and Gender in Neurodegenerative Diseases

      Submit here before September 30, 2024

      About Neurodegenerative Diseases: 1.9 Impact Factor I 5.9 CiteScore I 0.648 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found

      Progressive Neurological Decline with Deep Bilateral Imaging Changes: A Protean Presentation of Dural Arteriovenous Fistulae

      case-report

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Intracranial dural arteriovenous fistulae (DAVF) within the deep cerebral vasculature are diagnostically challenging because of their variable clinical presentation and typical bilateral neuroimaging findings mimicking inflammatory, infectious, and metabolic processes. Increasingly, reports have emerged highlighting the diagnostic and treatment challenges of these lesions and their associated high morbidity and rapid clinical deterioration when untreated. We describe here a case series of 4 patients with deep cerebral DAVF who presented with impaired arousal or memory and behavioral changes. In all patients, the initial differential diagnosis included metabolic, inflammatory, infectious, or neoplastic disease, with an eventual correct diagnosis obtained after catheter angiography had demonstrated arterialization of the deep venous structures, including the vein of Galen. All patients were successfully treated with endovascular embolization, with 1 patient requiring additional surgical treatment. We review the contemporary diagnostic evaluation and management of DAVF within the deep cerebral vasculature. With rapid diagnosis and treatment, a favorable outcome is possible.

          Related collections

          Author and article information

          Journal
          INE
          INE
          10.1159/issn.1664-5545
          Interventional Neurology
          S. Karger AG
          1664-9737
          1664-5545
          2018
          April 2018
          27 March 2018
          : 7
          : 5
          : 256-264
          Affiliations
          [_a] aDepartment of Neurology, Brigham and Women’s Hospital/Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA
          [_b] bDepartment of Neurosurgery, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA
          [_c] cDepartment of Radiology, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA
          [_d] dDepartments of Neurosurgery and Radiology, Brigham and Women’s Hospital/Harvard Medical School, Boston, Massachusetts, USA
          Author notes
          *Thabele M. Leslie-Mazwi, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 (USA), E-Mail tleslie-mazwi@mgh.harvard.edu
          Article
          487332 PMC5939689 Intervent Neurol 2018;7:256–264
          10.1159/000487332
          PMC5939689
          29765395
          9c1c8845-30ea-4c66-9b3b-df1b6e694d47
          © 2018 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          : 28 October 2017
          : 31 January 2018
          Page count
          Figures: 4, Tables: 1, Pages: 9
          Categories
          Original Paper

          Geriatric medicine,Neurology,Cardiovascular Medicine,Neurosciences,Clinical Psychology & Psychiatry,Public health
          Deep venous system,MRI,Neurological decline,Onyx embolization,Bilateral edema,Venous hypertension,Dural arteriovenous fistula

          Comments

          Comment on this article